CFCarole Faviez

Carole Faviez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carole Faviez has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A diagnosis support system to identify rare disease cases in large-scale clinical databases : application to ciliopathies

    by Carole Faviez

    Système d’aide au diagnostic pour l’identification de patients atteints de maladies rares au sein de grandes bases de données cliniques : application aux ciliopathies: Contexte : Il existe plus de 7000 maladies rares qui touchent environ 400 millions de personnes dans le monde. Les problèmes de sous diagnostic, retard de diagnostic et d’erreur de diagnostic sont fréquents. Dans le contexte du projet C’IL-LICO, coordonné par l’institut Imagine, l’objectif de cette thèse est de développer un système d’aide au diagnostic des ciliopathies, maladies rares monogéniques complexes caractérisées par une forte hétérogénéité phénotypique et génétique, à partir du phénotypage profond des dossiers médicaux électroniques. Méthode : Dr Warehouse, l’entrepôt de données de l’hôpital Necker, permet l’extraction automatique des entités cliniques présentes au sein des dossiers médicaux électroniques à partir de l’UMLS. Notre méthodologie comprend 5 étapes. (i) Dans un premier temps, nous avons réalisé une revue de la littérature des systèmes d’aide au diagnostic pour les maladies rares. (ii) Ensuite, nous avons évalué la capacité de systèmes génériques d’aide au diagnostic des maladies rares à identifier les patients atteints de ciliopathies au sein de Dr Warehouse. (iii) Notre premier pas vers la conception d’un système dédiés aux ciliopathies a consisté à explorer les méthodes de machine learning en considérant différentes hypothèses. (iv) A partir des résultats de cette analyse, afin d’améliorer le phénotypage des patients, nous avons proposé une nouvelle approche combinant une méthode d’extraction basée sur les thésaurus au deep learning que nous avons évaluée sur le syndrome de Jeune, un type de ciliopathie caractérisé par des anomalies squelettiques. (v) En parallèle, nous avons conçu un pipeline d’apprentissage supervisé pour la détection de ciliopathies avec mutation du gène NPHP1 associant un module de similarité sémantique (hiérarchique ou word embeddings), une étape de sélection de variables, une étape de sous échantillonnage, et une étape de classification incluant une répétition de cycles d’apprentissage-test. Résultats : Alors que la plupart des systèmes utilisant des phénotypes jusqu’en 2020 étaient des systèmes de « recommandation de maladies » basés sur les connaissances, des approches « data driven » ont été récemment développées. Nous avons proposé quatre recommandations pour le développement d’un système d’aide au diagnostic des maladies rares : utiliser des terminologies standards, combiner les connaissances expertes avec le machine learning, prendre en compte le déséquilibre et la grande dimensionnalité des données, et évaluer les résultats sur des patients réels. Les systèmes génériques testés n’ont pas obtenu de résultats satisfaisants. Trois défis principaux ont été identifiés : prendre en compte la qualité des données et améliorer l’extraction des phénotypes depuis le texte libre, et prendre en compte la complexité des ciliopathies. Notre analyse préliminaire a confirmé que la présence de patients mal phénotypés entravait les performances des systèmes de classification basés sur le machine learning. Concernant le phénotypage des patients, notre méthode hybride a permis de multiplier par 2,5 la détection d’anomalies squelettiques par rapport au module initial de Dr Warehouse. Enfin, le pipeline d’apprentissage automatique que nous avons conçu a été appliqué à 30 patients avec mutation du gène NPHP1 et 7231 contrôles. De très bons résultats ont été obtenus, en particulier avec une version limitée aux relations ascendant-descendant de la similarité de Lin avec des forêts aléatoires (sensibilité de 85% pour une spécificité de 90%). Notre approche pourrait être utilisée pour le pré-diagnostic avant confirmation génétique dans un contexte clinique. Conclusion : Cette thèse apporte de nombreuses perspectives quant à l’enrichissement du phénotypage des patients et des approches qui pourraient être implémentées dans le cadre de systèmes d’information clinique pour accélérer le diagnostic de patients. Les méthodes conçues peuvent être généralisées pour d’autres maladies rares complexes.

  • Open Access

    Longitudinal information extraction from clinical notes in rare diseases: an efficient approach with small language models

    by Xiaomeng Wang, Carole Faviez, Marc Vincent, Judith Jeyafreeda Andrew, Emma Le Priol, Sophie Saunier, Bertrand Knebelmann, Rui Zhang, Nicolas Garcelon, Anita Burgun, et al.

    Objectives: Rare diseases often require longitudinal monitoring to characterise progression, yet much clinical information remains locked in unstructured electronic health records (EHRs). Efficient recovery of such data is critical for accurate prognostic modelling and clinical trial preparation. We aimed to develop and evaluate a small language model (SLM)-based pipeline for extracting longitudinal information from French clinical notes of patients with rare kidney diseases. Methods: As a use case, we focused on serum creatinine, a key biomarker of kidney function. We analyzed 81 clinical notes comprising 200 measurements (triplet of date, value and unit). Four open-source SLMs (Mistral-7B, Llama-3.2-3B, Qwen3-4B, Qwen3-8B) were systematically tested with different prompting strategies in French and English. Outputs were post-processed to standardize formats and resolve inconsistencies, and performance was assessed across model size, prompting, language, and robustness to text duplication. Results: All SLMs extracted structured triplets, with F1-scores ranging from 0.519 to 0.928 (Qwen3-8B), outperforming the rule-based baseline. Larger models generally performed better, while prompting strategy and language had modest effects across models. SLMs also showed variable robustness to duplicated content common in real-world EHR notes. Discussion: Lightweight, locally deployable language models can accurately extract longitudinal biomarkers from unstructured clinical notes. Our findings highlight their practicality for rare diseases where data scarcity often limits task-specific model training. Conclusion: SLMs provide a privacy-preserving and resource-efficient solution for recovering longitudinal biomarker trajectories from unstructured notes, offering potential to advance real-world research and patient care in rare kidney diseases. 1) What is already known?: Longitudinal monitoring is essential in rare kidney diseases, yet key biomarker data are often locked in unstructured clinical notes. Large language models (LLMs) have shown strong performance in clinical text processing tasks but face major challenges related to privacy, computational cost, and implementation feasibility in healthcare settings. Small language models (SLMs) are emerging as lightweight, locally deployable alternatives whose potential for clinical applications is increasingly recognized. 2) What does this paper add?: This study provides the first real-world evaluation of SLMs for extracting longitudinal biomarker measurements in rare kidney disease cohorts. It introduces and validates an efficient extraction pipeline that combines document preselection, SLM prompting, and post-processing to accurately retrieve biomarker measurements from French clinical notes. The findings show that SLM-based extraction can help mitigate data scarcity in rare diseases, thereby improving prognosis modeling and supporting clinical research.


  • Open Access

    Enhancing rare disease detection with deep phenotyping from EHR narratives: evaluation on Jeune syndrome

    by Carole Faviez, Xiaomeng Wang, Marc Vincent, Nicolas Garcelon, Sophie Saunier, Valérie Cormier-Daire, Xiaoyi Chen, Anita Burgun


  • Open Access

    Objectivizing issues in the diagnosis of complex rare diseases: lessons learned from testing existing diagnosis support systems on ciliopathies

    by Carole Faviez, Xiaoyi Chen, Nicolas Garcelon, Mohamad Zaidan, Katy Billot, Friederike Petzold, Hassan Faour, Maxime Douillet, Jean-Michel Rozet, Valérie Cormier-Daire, et al.

    Background: There are approximately 8,000 different rare diseases that affect roughly 400 million people worldwide. Many of them suffer from delayed diagnosis. Ciliopathies are rare monogenic disorders characterized by a significant phenotypic and genetic heterogeneity that raises an important challenge for clinical diagnosis. Diagnosis support systems (DSS) applied to electronic health record (EHR) data may help identify undiagnosed patients, which is of paramount importance to improve patients’ care. Our objective was to evaluate three online-accessible rare disease DSSs using phenotypes derived from EHRs for the diagnosis of ciliopathies. Methods: Two datasets of ciliopathy cases, either proven or suspected, and two datasets of controls were used to evaluate the DSSs. Patient phenotypes were automatically extracted from their EHRs and converted to Human Phenotype Ontology terms. We tested the ability of the DSSs to diagnose cases in contrast to controls based on Orphanet ontology. Results: A total of 79 cases and 38 controls were selected. Performances of the DSSs on ciliopathy real world data (best DSS with area under the ROC curve = 0.72) were not as good as published performances on the test set used in the DSS development phase. None of these systems obtained results which could be described as “expert-level”. Patients with multisystemic symptoms were generally easier to diagnose than patients with isolated symptoms. Diseases easily confused with ciliopathy generally affected multiple organs and had overlapping phenotypes. Four challenges need to be considered to improve the performances: to make the DSSs interoperable with EHR systems, to validate the performances in real-life settings, to deal with data quality, and to leverage methods and resources for rare and complex diseases. Conclusion: Our study provides insights into the complexities of diagnosing highly heterogenous rare diseases and offers lessons derived from evaluation existing DSSs in real-world settings. These insights are not only beneficial for ciliopathy diagnosis but also hold relevance for the enhancement of DSS for various complex rare disorders, by guiding the development of more clinically relevant rare disease DSSs, that could support early diagnosis and finally make more patients eligible for treatment.


  • Open Access

    Performance and clinical utility of a new supervised machine-learning pipeline in detecting rare ciliopathy patients based on deep phenotyping from electronic health records and semantic similarity

    by Carole Faviez, Marc Vincent, Nicolas Garcelon, Olivia Boyer, Bertrand Knebelmann, Laurence Heidet, Sophie Saunier, Xiaoyi Chen, Anita Burgun

    Background: Rare diseases affect approximately 400 million people worldwide. Many of them suffer from delayed diagnosis. Among them, NPHP1-related renal ciliopathies need to be diagnosed as early as possible as potential treatments have been recently investigated with promising results. Our objective was to develop a supervised machine learning pipeline for the detection of NPHP1 ciliopathy patients from a large number of nephrology patients using electronic health records (EHRs). Methods and results: We designed a pipeline combining a phenotyping module re-using unstructured EHR data, a semantic similarity module to address the phenotype dependence, a feature selection step to deal with high dimensionality, an undersampling step to address the class imbalance, and a classification step with multiple train-test split for the small number of rare cases. The pipeline was applied to thirty NPHP1 patients and 7231 controls and achieved good performances (sensitivity 86% with specificity 90%). A qualitative review of the EHRs of 40 misclassified controls showed that 25% had phenotypes belonging to the ciliopathy spectrum, which demonstrates the ability of our system to detect patients with similar conditions. Conclusions: Our pipeline reached very encouraging performance scores for pre-diagnosing ciliopathy patients. The identified patients could then undergo genetic testing. The same data-driven approach can be adapted to other rare diseases facing underdiagnosis challenges.


  • Open Access

    Assessment of the Early Detection of Anosmia and Ageusia Symptoms in COVID-19 on Twitter: Retrospective Study

    by Carole Faviez, Manissa Talmatkadi, Pierre Foulquié, Adel Mebarki, Stéphane Schück, Anita Burgun, Xiaoyi Chen

    Background: During the unprecedented COVID-19 pandemic, social media has been extensively used to amplify the spread of information and to express personal health-related experiences regarding symptoms, including anosmia and ageusia, 2 symptoms that have been reported later than other symptoms. Objective: Our objective is to investigate to what extent Twitter users reported anosmia and ageusia symptoms in their tweets and if they connected them to COVID-19, to evaluate whether these symptoms could have been identified as COVID-19 symptoms earlier using Twitter rather than the official notice. Methods: We collected French tweets posted between January 1, 2020, and March 31, 2020, containing anosmia- or ageusia-related keywords. Symptoms were detected using fuzzy matching. The analysis consisted of 3 parts. First, we compared the coverage of anosmia and ageusia symptoms in Twitter and in traditional media to determine if the association between COVID-19 and anosmia or ageusia could have been identified earlier through Twitter. Second, we conducted a manual analysis of anosmia- and ageusia-related tweets to obtain quantitative and qualitative insights regarding their nature and to assess when the first associations between COVID-19 and these symptoms were established. We randomly annotated tweets from 2 periods: the early stage and the rapid spread stage of the epidemic. For each tweet, each symptom was annotated regarding 3 modalities: symptom (yes or no), associated with COVID-19 (yes, no, or unknown), and whether it was experienced by someone (yes, no, or unknown). Third, to evaluate if there was a global increase of tweets mentioning anosmia or ageusia in early 2020, corresponding to the beginning of the COVID-19 epidemic, we compared the tweets reporting experienced anosmia or ageusia between the first periods of 2019 and 2020. Results: In total, 832 (respectively 12,544) tweets containing anosmia (respectively ageusia) related keywords were extracted over the analysis period in 2020. The comparison to traditional media showed a strong correlation without any lag, which suggests an important reactivity of Twitter but no earlier detection on Twitter. The annotation of tweets from 2020 showed that tweets correlating anosmia or ageusia with COVID-19 could be found a few days before the official announcement. However, no association could be found during the first stage of the pandemic. Information about the temporality of symptoms and the psychological impact of these symptoms could be found in the tweets. The comparison between early 2020 and early 2019 showed no difference regarding the volumes of tweets. Conclusions: Based on our analysis of French tweets, associations between COVID-19 and anosmia or ageusia by web users could have been found on Twitter just a few days before the official announcement but not during the early stage of the pandemic. Patients share qualitative information on Twitter regarding anosmia or ageusia symptoms that could be of interest for future analyses.


  • Open Access

    Assessment of the Early Detection of Anosmia and Ageusia Symptoms in COVID-19 on Twitter: Retrospective Study (Preprint)

    by Carole Faviez, Manissa Talmatkadi, Pierre Foulquié, Adel Mebarki, Stéphane Schück, Anita Burgun, Xiaoyi Chen

    BACKGROUND During the unprecedented COVID-19 pandemic, social media has been extensively used to amplify the spread of information and to express personal health-related experiences regarding symptoms, including anosmia and ageusia, 2 symptoms that have been reported later than other symptoms. OBJECTIVE Our objective is to investigate to what extent Twitter users reported anosmia and ageusia symptoms in their tweets and if they connected them to COVID-19, to evaluate whether these symptoms could have been identified as COVID-19 symptoms earlier using Twitter rather than the official notice. METHODS We collected French tweets posted between January 1, 2020, and March 31, 2020, containing anosmia- or ageusia-related keywords. Symptoms were detected using fuzzy matching. The analysis consisted of 3 parts. First, we compared the coverage of anosmia and ageusia symptoms in Twitter and in traditional media to determine if the association between COVID-19 and anosmia or ageusia could have been identified earlier through Twitter. Second, we conducted a manual analysis of anosmia- and ageusia-related tweets to obtain quantitative and qualitative insights regarding their nature and to assess when the first associations between COVID-19 and these symptoms were established. We randomly annotated tweets from 2 periods: the early stage and the rapid spread stage of the epidemic. For each tweet, each symptom was annotated regarding 3 modalities: symptom (yes or no), associated with COVID-19 (yes, no, or unknown), and whether it was experienced by someone (yes, no, or unknown). Third, to evaluate if there was a global increase of tweets mentioning anosmia or ageusia in early 2020, corresponding to the beginning of the COVID-19 epidemic, we compared the tweets reporting experienced anosmia or ageusia between the first periods of 2019 and 2020. RESULTS In total, 832 (respectively 12,544) tweets containing anosmia (respectively ageusia) related keywords were extracted over the analysis period in 2020. The comparison to traditional media showed a strong correlation without any lag, which suggests an important reactivity of Twitter but no earlier detection on Twitter. The annotation of tweets from 2020 showed that tweets correlating anosmia or ageusia with COVID-19 could be found a few days before the official announcement. However, no association could be found during the first stage of the pandemic. Information about the temporality of symptoms and the psychological impact of these symptoms could be found in the tweets. The comparison between early 2020 and early 2019 showed no difference regarding the volumes of tweets. CONCLUSIONS Based on our analysis of French tweets, associations between COVID-19 and anosmia or ageusia by web users could have been found on Twitter just a few days before the official announcement but not during the early stage of the pandemic. Patients share qualitative information on Twitter regarding anosmia or ageusia symptoms that could be of interest for future analyses.

  • Open Access

    Concerns Discussed on Chinese and French Social Media During the COVID-19 Lockdown: Comparative Infodemiology Study Based on Topic Modeling

    by Stéphane Schück, Pierre Foulquié, Adel Mebarki, Carole Faviez, Mickaïl Khadhar, Nathalie Texier, Sandrine Katsahian, Anita Burgun, Xiaoyi Chen

    Background: During the COVID-19 pandemic, numerous countries, including China and France, have implemented lockdown measures that have been effective in controlling the epidemic. However, little is known about the impact of these measures on the population as expressed on social media from different cultural contexts. Objective: This study aims to assess and compare the evolution of the topics discussed on Chinese and French social media during the COVID-19 lockdown. Methods: We extracted posts containing COVID-19–related or lockdown-related keywords in the most commonly used microblogging social media platforms (ie, Weibo in China and Twitter in France) from 1 week before lockdown to the lifting of the lockdown. A topic model was applied independently for three periods (prelockdown, early lockdown, and mid to late lockdown) to assess the evolution of the topics discussed on Chinese and French social media. Results: A total of 6395; 23,422; and 141,643 Chinese Weibo messages, and 34,327; 119,919; and 282,965 French tweets were extracted in the prelockdown, early lockdown, and mid to late lockdown periods, respectively, in China and France. Four categories of topics were discussed in a continuously evolving way in all three periods: epidemic news and everyday life, scientific information, public measures, and solidarity and encouragement. The most represented category over all periods in both countries was epidemic news and everyday life. Scientific information was far more discussed on Weibo than in French tweets. Misinformation circulated through social media in both countries; however, it was more concerned with the virus and epidemic in China, whereas it was more concerned with the lockdown measures in France. Regarding public measures, more criticisms were identified in French tweets than on Weibo. Advantages and data privacy concerns regarding tracing apps were also addressed in French tweets. All these differences were explained by the different uses of social media, the different timelines of the epidemic, and the different cultural contexts in these two countries. Conclusions: This study is the first to compare the social media content in eastern and western countries during the unprecedented COVID-19 lockdown. Using general COVID-19–related social media data, our results describe common and different public reactions, behaviors, and concerns in China and France, even covering the topics identified in prior studies focusing on specific interests. We believe our study can help characterize country-specific public needs and appropriately address them during an outbreak.


  • Open Access

    Mapping and Modeling of Discussions Related to Gastrointestinal Discomfort in French-Speaking Online Forums: Results of a 15-Year Retrospective Infodemiology Study

    by Florent Schäfer, Carole Faviez, Paméla Voillot, Pierre Foulquié, Matthieu Najm, Jean-François Jeanne, Guy Fagherazzi, Stéphane Schück, Boris Le Nevé

    Background: Gastrointestinal (GI) discomfort is prevalent and known to be associated with impaired quality of life. Real-world information on factors of GI discomfort and solutions used by people is, however, limited. Social media, including online forums, have been considered a new source of information to examine the health of populations in real-life settings. Objective: The aims of this retrospective infodemiology study are to identify discussion topics, characterize users, and identify perceived determinants of GI discomfort in web-based messages posted by users of French social media. Methods: Messages related to GI discomfort posted between January 2003 and August 2018 were extracted from 14 French-speaking general and specialized publicly available online forums. Extracted messages were cleaned and deidentified. Relevant medical concepts were determined on the basis of the Medical Dictionary for Regulatory Activities and vernacular terms. The identification of discussion topics was carried out by using a correlated topic model on the basis of the latent Dirichlet allocation. A nonsupervised clustering algorithm was applied to cluster forum users according to the reported symptoms of GI discomfort, discussion topics, and activity on online forums. Users’ age and gender were determined by linear regression and application of a support vector machine, respectively, to characterize the identified clusters according to demographic parameters. Perceived factors of GI discomfort were classified by a combined method on the basis of syntactic analysis to identify messages with causality terms and a second topic modeling in a relevant segment of phrases. Results: A total of 198,866 messages associated with GI discomfort were included in the analysis corpus after extraction and cleaning. These messages were posted by 36,989 separate web users, most of them being women younger than 40 years. Everyday life, diet, digestion, abdominal pain, impact on the quality of life, and tips to manage stress were among the most discussed topics. Segmentation of users identified 5 clusters corresponding to chronic and acute GI concerns. Diet topic was associated with each cluster, and stress was strongly associated with abdominal pain. Psychological factors, food, and allergens were perceived as the main causes of GI discomfort by web users. Conclusions: GI discomfort is actively discussed by web users. This study reveals a complex relationship between food, stress, and GI discomfort. Our approach has shown that identifying web-based discussion topics associated with GI discomfort and its perceived factors is feasible and can serve as a complementary source of real-world evidence for caregivers.


  • Open Access

    Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

    by François-Emery Cotté, Paméla Voillot, Bryan Bennett, Bruno Falissard, Christophe Tzourio, Pierre Foulquié, Anne-Françoise Gaudin, Hervé Lemasson, Valentine Grumberg, Laura McDonald, et al.

    Background: Immune checkpoint inhibitors (ICIs) are increasingly used to treat several types of tumors. Impact of this emerging therapy on patients’ health-related quality of life (HRQoL) is usually collected in clinical trials through standard questionnaires. However, this might not fully reflect HRQoL of patients under real-world conditions. In parallel, users’ narratives from social media represent a potential new source of research concerning HRQoL. Objective: The aim of this study is to assess and compare coverage of ICI-treated patients’ HRQoL domains and subdomains in standard questionnaires from clinical trials and in real-world setting from social media posts. Methods: A retrospective study was carried out by collecting social media posts in French language written by internet users mentioning their experiences with ICIs between January 2011 and August 2018. Automatic and manual extractions were implemented to create a corpus where domains and subdomains of HRQoL were classified. These annotations were compared with domains covered by 2 standard HRQoL questionnaires, the EORTC QLQ-C30 and the FACT-G. Results: We identified 150 users who described their own experience with ICI (89/150, 59.3%) or that of their relative (61/150, 40.7%), with 137 users (91.3%) reporting at least one HRQoL domain in their social media posts. A total of 8 domains and 42 subdomains of HRQoL were identified: Global health (1 subdomain; 115 patients), Symptoms (13; 76), Emotional state (10; 49), Role (7; 22), Physical activity (4; 13), Professional situation (3; 9), Cognitive state (2; 2), and Social state (2; 2). The QLQ-C30 showed a wider global coverage of social media HRQoL subdomains than the FACT-G, 45% (19/42) and 29% (12/42), respectively. For both QLQ-C30 and FACT-G questionnaires, coverage rates were particularly suboptimal for Symptoms (68/123, 55.3% and 72/123, 58.5%, respectively), Emotional state (7/49, 14% and 24/49, 49%, respectively), and Role (17/22, 77% and 15/22, 68%, respectively). Conclusions: Many patients with cancer are using social media to share their experiences with immunotherapy. Collecting and analyzing their spontaneous narratives are helpful to capture and understand their HRQoL in real-world setting. New measures of HRQoL are needed to provide more in-depth evaluation of Symptoms, Emotional state, and Role among patients with cancer treated with immunotherapy.